As illustrated in Figure 3A, treatment with NaHS (100 μmol/kg/day, i.p., for 4 weeks) significantly increased the time of rats spending exploring novel objects than familiar objects in CRS-exposed rats, while administration of Anti-Acrp30 (1 μg/day, i.c.v., for 1 week) obviously decreased the time of rats spending exploring novel objects than familiar objects in rats co-treated with NaHS and CRS. This evidence concerns the gene ADIPOQ and congenital rubella syndrome.